Clinical Trial Update: Bevacizumab in Combination With Vinorelbine and Trastuzumab for HER2-Positive, Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial assessed the safety and efficacy of bevacizumab in combination with vinorelbine and trastuzumab for HER2-positive metastatic breast cancer; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• HERCEPTIN (trastuzumab)
• Navelbine (vinorelbine)

Snippet

Sponsor: Harold J. Burstein, MD, PhD | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-05-13